InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Tuesday, 02/07/2017 8:21:48 AM

Tuesday, February 07, 2017 8:21:48 AM

Post# of 2794
EXCELLENT Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma


? Download as PDF
February 07, 2017
- Phase 1 trial will evaluate Actimab-M in treating patients with multiple myeloma who are unresponsive to currently available therapies

- Clinical trial initiated at Texas Oncology - Baylor Charles A. Sammons Cancer Center in Dallas, TX to be conducted by Principal Investigator and Trial Sponsor, Dr. Yair Levy

- Clinical pipeline now includes Iomab-B pivotal Phase 3 trial, Actimab-A Phase 2 trial and Actimab-M Phase 1 trial

http://www.actiniumpharma.com/news-media/press-releases/detail/214/actinium-pharmaceuticals-announces-pipeline-expansion-with

Time to fry some shorts.

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News